Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Unfortunately shareprice is at the level of spring 2012, spring 2013 etc. If we ignore the enormous short squezze this years - we are with this story where we have been in the beginning - with the difference that many got caught and lost faith
By the way, I would prefer business insteed of another promising news about erectile dysfunction products. However, the market does see it the same way - even if PLPL will release that they found a product against all kind of cancer. Nobody will believe it as long as PLPL does not FINALLY deliver revenues.
Who is 'our' by the way?
IHub does not publish PLPL news anymore obvioulsy. Strange.
tmonkey spoke about SEC andn ot about the status of PLPL. Emotional relationship to a pennystcok like PLPL is useless as long PLPL does not run a proper business. If this shall be wrong than speculators since 500 years who believe in fundamentals, would have been all wrong. As long as PLPL presents wonderful hopes abouzt their extracts, but did not deliver, as
long this is a non-trustworthy speculation with an option to become a running company! The longer PLPL does not deliver trust the more it can be in the focus of the SEC after a 'special' period. This is a fact for all pennystocks - it it does not mean that PLPL is already a scam. Currently it is NOTHING but a hope with little gambler ))
However, PLPL is still worth of course to be on the watchlist or in the portfolio with 5% of the value of a portfolio. Already a lot.
As always, just IMO
Where do I say already 'they are a scam"?:
"But this is the story of 99% of high risk pennystocks and the SEC has a hard look to all US pennies - included PLPL obvioulsy and unfortunately.
As PLPL is listed in USA but is running the compnay at Africa, I do not wonder at all that the SEC doesn't like this: Too often pennystocks just have a post box fake compnay in the States and play 'running company' in the third world. Guess why!
I hope Plandai proves VERY FAST that it is a serious story - otherwise ....well, I must not explain what happens to the shareprice, right?!"
Plandai does nothing but releases since two years, Plandai has a post box bureau in USA but the listed compnay in Africa, Plandai pays a lot of promotion for a lot of money, Plandai management pay themselves millions of salaries, but exists on loans only ........PLEASE, how could the SEC trust pennystock Plandai 100% ?
This is what I said iwth my words - and nothing else. I do not trust Plandai management at all, but I think it is a good speculation ! I am not in love with the stock - especially not when I see the chart desaster. Do you adore the chart and the company?
tmonkey, don't forget: your broker/bank will not 'let you go' anyway at any price- if PLPL is off their list, selling is impossible as well. My experience! You should find a new broker urgently who trades PLPL
Well, I know this already since the stock was going up to 3.00. I told my european broker to sell and he said, PLPL is not on their list anymore since some days (!) - which did mean that I have bought at .16 and could not sell at 3.00 because my european broker stopped trading PLPL (I 'lost' the chance of tons of $). So I had to change broker - which took a while to transfer the PLPL shares to the other broker - finally it was much too late for the great gain. I was really exploding.
But this is the story of 99% of high risk pennystocks and the SEC has a hard look to all US pennies - included PLPL obvioulsy and unfortunately.
As PLPL is listed in USA but is running the compnay at Africa, I do not wonder at all that the SEC doesn't like this: Too often pennystocks just have a post box fake compnay in the States and play 'running company' in the third world. Guess why!
I hope Plandai proves VERY FAST that it is a serious story - otherwise ....well, I must not explain what happens to the shareprice, right?!
(tmonkey, are you by chance from Europe too?)
Another coverage news: Sept 10th
Plandai Biotechnology's Green Tea Extract Delivers Favorable Preliminary Results in Human Clinical Trial Conducted in South Africa
Plandai Biotechnology, Inc. September 10, 2014 9:00 AM
NEW YORK, NY--(Marketwired - Sep 10, 2014) - Plandaí Biotechnology (OTCQB: PLPL) recently released the preliminary results from its human clinical trial where the company's green tea extract, Phytofare™ Catechin Complex, was clinically tested and compared to a commercially available green tea extract. In the clinical trial, Plandaí's Phytofare™ extract product showed greater bioavailability to participants than did the commercial extract by a factor of 10.
These results echo the USDA's findings that were published in 2012. The USDA concluded that Plandaí's proprietary extraction process for treating vegetable matter provides more bioavailability and more benefit to consumers. So, now in 2014, we're presented with even more evidence that the extraction process delivers greater bioavailability with this clinical trial conducted in South Africa by North West University.
Plandaí's extract has now shown in the preliminary results of a clinical trial that it can deliver more of what many believe makes green tea healthy. View the preliminary results: http://www.plandaibiotech.com/bioavailability_trial_preliminary_results.pdf
In an article written for WebMD, several researchers rave about the benefits of green tea, including, Beth Reardon, RD, a Boston nutritionist, who said of green tea's biggest benefit, "It's all about the catechin content." Catechins are a type of antioxidant found in the greatest abundance in the leaves of the tea plant.
The article states that green tea has been shown to improve blood flow and lower cholesterol, and says a 2013 review of many studies found green tea helped prevent a range of heart-related issues, from high blood pressure to congestive heart failure.
For the health benefits of the green tea plant to be realized and to be beneficial, however, the catechins have to be absorbed into the body and then remain in the bloodstream long enough to be effective.
According to Professor Anne Grobler of North West University, Plandaí's product showed that by using the company's extraction process, which unzips and reconfigures the plant's molecules to be more accepted by the human body, with Phytofare™ all 8 of the plant's catechins were present in the bloodstream versus only 2 catechins detected in the bloodstream when the commercial extract was tested.
Additionally, the trial's results found that when using the company's technology, absorption of those catechins was 5 times greater, and the life span of the catechin's molecules in the bloodstream was doubled in Phytofare™ when compared to that of the commercial green tea extract.
The significance of these results to Plandaí is that an extract that allows the body to experience more of the health benefits of green tea is expected to have a significant market advantage over traditional green tea products where most of the catechins are lost through metabolization before they ever enter the bloodstream. Simply put, Plandaí's product delivers significantly more of the nutrients and then those nutrients remain in the bloodstream twice as long.
About Stock Market Media Group
SMMG is a Research and Content Development IR firm offering a platform for corporate stories to unfold in the media with Reports, Interviews and Articles. SMMG is being compensated $3,500 per month by Plandai Biotechnology, Inc. for the creation of these materials. In the past, SMMG was compensated for similar activities by a third party. These prior activities occurred during the period from April 2013 through June 2014. During that period, SMMG received approximately $55,000 for its efforts. Neither SMMG nor anyone associated with it own shares in Plandai Biotechnology. For more information: www.stockmarketmediagroup.com.
Hope this stock market media coverage helps a bit.
Tue, Sep 16, 2014, 3:47pm
Plandai Biotechnology Gains Competitive Advantage With Preliminary Clinical Trial Results
Plandai Biotechnology, Inc. September 15, 2014 9:00 AM
NEW YORK, NY--(Marketwired - Sep 15, 2014) - Plandaí Biotechnology (OTCQB: PLPL) expects to begin commercial production of its green tea extract, Phytofare™ Catechin Complex, in the coming weeks when the first green tea crop of the season is ready for processing at the company's 8,000 acre Senteeko facility in South Africa. After receiving positive preliminary results from a human clinical trial that showed Plandaí's product offers ten times more bioavailability than the commercially available extract it was compared to, the company could gain a competitive advantage over other less potent extracts.
The results from the clinical trial, conducted in South Africa by North West University, will allow Plandaí to advertise exactly what consumers are looking for -- a more potent green tea extract. When consumers shop for health products, they're looking for those that have proven themselves in clinical trials, and, in turn, can boast of higher bioavailability.
Bioavailability is essentially the measure of how much of a drug or supplement is able to be absorbed into the bloodstream and how long it can remain there so that the body can realize its health benefits. In the case of Plandaí's green tea extract, the results should offer exactly what consumers want.
The benefit to those using the company's Phytofare™ Catechin Complex is that with higher bioavailability or absorption rate, the phytonutrients are in the bloodstream in greater quantities and for twice as long, and this should help the company become competitive in the market.
The global tea market is estimated at over $50 billion while Vitamin Shoppe estimates the US nutritional supplements industry alone is over $29 billion, and growing at 5.4% per year. Driven by increasingly educated consumers, with a heightened focus on living longer, feeling younger, living healthy and naturally, GNC now generates $1.2 billion online and through 6,300 retail stores, serving as a barometer of the magnitude of the market opportunity.
Plandaí provides higher bioavailability in its green tea extract by using a unique and proprietary process known as "hydrodynamic sheering" which unzips the molecules of the "live" green tea plant, releases all of the phytonutrients, and then rearranges the molecules into a biocompatible format. This process, which has now been scientifically validated in tomatoes and green tea, could potentially be utilized for all polyene-based molecules -- opening the door for Plandaí to tap the potential of many different plants that have known medical benefits.
Green tea's health benefits come from the 8 catechins, a type of antioxidant, found in the leaves of the plant. In Plandaí's clinical trial, all 8 of those catechins were present in the bloodstream versus only two found when participants used the commercial extract used in the clinical testing. Phytofare™ also provided 5 times greater absorption of those catechins, and the clinical trial found that the life span of the catechin's molecules in the bloodstream was doubled in Phytofare™.
View the preliminary results: http://www.plandaibiotech.com/bioavailability_trial_preliminary_results.pdf
About Stock Market Media Group
SMMG is a Research and Content Development IR firm offering a platform for corporate stories to unfold in the media with Reports, Interviews and Articles. SMMG is being compensated $3,500 per month by Plandai Biotechnology, Inc. for the creation of these materials. In the past, SMMG was compensated for similar activities by a third party. These prior activities occurred during the period from April 2013 through June 2014. During that period, SMMG received approximately $55,000 for its efforts. Neither SMMG nor anyone associated with it own shares in Plandai Biotechnology. For more information: www.stockmarketmediagroup.com.
Contact:
Stock Market Media Group
there will be no earnings this year....there are no sales of product as the product not ready for sale. Plain and simple - and the worst what PLPL management can do with shareholder.
Below .20 will be questionble, but .20 - -25 is absolutely an option again.
Just read the release since last months compared to the last two years - poor as poor can be.
Well, but I think it - neither to be negatiuve nor to be positive - will help anybody. But definitive fact is: This story became an absolutely disappointment in business, in non-ready products and IMO another year of no revenues. Remeber what the company said: This is the year. Three months left this year..... for making those $ 30.000.000 of revenues as promised for 2013 already - with WHICH product? LOL
If this does not disappoint shareholder....I ask myself what else has to happen!
Ok, I forgot....this is a ten-bagger like all other pennies are for some months LOL
I also thought on investing another $30k but not while this volatility based on nothing fundamental. Still waiting for .20+ - an option if PLPL keeps going on like that - some green days don't change facts.
(BTW, guess next comment to my thoughts will be 'beware, he ba§hes to get in cheap' - a slogan around at bullboards for two decades since existing of critical and careful shareholder who express their thoughts )))
Be negative about me, no problem LOL. But fortunately the stockamrket seems to be more realistic about this risky penny play than some believers. I hope PLPL will do it, but currently management forces worst predictions - quod erat demonstrandum - and obvioulsy hundreds of stockmarket member agree with me.
However, again, whish you really good luck with the 'big' money by PLPL you both hope for. Unfortunately I have seen so many believers in the mud after two years in a pennystock -. and all disappear quietly. Hope you still are here in 2016 ))
By the way, I would love to be proved that negative predictions of mine are TOTALLY wrong - as I would make money as well. But I do not wear rose glasses - and the chart speaks for itself - as much as Shively - in the opposite - does not speak at all anymore !!!!!!!!!
read posts properly - especially if I even refer directly to my prediction. Thank you.
Prediction of 'too early' is not relevant. Chart technique, moementum etc. has shown on friday what will come monday - IF no news be published. We will close either red, even or just 1-2 % plus. This week will be a 'drop week' again. As Spock would say: This is logical with regards to the chart, fundamentals and zero news.
as I predicted, just a bit faster. pity, this stock has no stability and chart has no reliability. Well, no delivery - not faith.
another year is a bit too much - this would prove a very low ability of this management. If revenues end of 2014 are ridiculous again, they destroy their reputation and 2015 would be another year without phytofare and whatever else they promise. It is anyway very strange that they are still not able mid of September 2014 to tell that products are on the way to shops. I start to worry phytofare might just be one of those biotech prodcuts with a lot of hoo-ha and nothing behind it but maybe a good tea (hopefully this as a tiny result for this efforts in Africa).
And - still no additional shops announced.
By the way, Plandai MUSt be running out of money. Curious how they go on to finance this year!
As we both simply hope for something here - you more, I less - let us hope it will finally have been worth the enormous waste of time with this penny play. But as for me it has been worth 190k free shares meanwhile already after the unrealistic 3.00 , I can not be that much upset as most of my pennyplays of the past decade are in hell meanwhile.
However, as I said, I am out with the next hype. But that will not be next week.
PS. Not sure anymore we will close green - candle got very short.
tmonkey, I prefer to believe in and study of momentum, chart technique in general, news flow, progress in word AND action by a company, etc.etc. I am happy about the little rebound which is just a reaction to the latest file.
But sorry, it is just one single file - currently, based on experiences, chart technique, news flow etc. this movement last three days does not promise anything more than this little rebound. If some like to believe in big money again - as usual after some green days - they have to, this is well-known stockmarket psychology. Fine, but not my way of following a listed - and yet - zero business penny microcap. I start to believe in PLPL when they deliver a product ready for sale and revenues- without such facts PLPL is nothing but a nice gamble.
Of course Iwill also be satified with a good gamble - but without dreaming.
Three white candles in row but the white candels are already getting shorter again after three days reaction to the file of PLPL. Guess we will close green today, but next week will start .32 to .34, so IMO nearly even with todays close. Next week will be boring as people will start to watch again if momentum grows or dies. As I do not expect additional news I think we will get back to .30 / .27 next friday.
Just IMO of course.
Have a good weekend all.
I believe in the stupity of the stockmarket to get thrilled by some releases - the management and the product did not prove yet to have value!
I believe in phases of momentums here and in short coverage.
As long as tghe management does deliver delays and delays - in what, the hell, shall we believe? Some are waiting for two years now and management has been able to deliver medical studies before the listing - phytofare already existed in 2012 ! So, sorry, I have no understanding and no faith currently. As I said, I speculate with the market moves/momentums at PLPL - the rest is not very promising yet - just the existence of Shively and the latest release by Duffield to avoid dilution - IF !!!! his arguments are honest - I also take into account that PLPL and Duffield did not receive the money because faith in the product is not that high - so he might just release a nice information for shareholder to keep his faces!
It is usual that shareholder are thrilled by every more or less significant news/release/information after such a drop - but it is unfortunately also usual that such thrill does not keep long if nothing else will be delivered by a company. So, if PLPL does not deliver anything else the thirll is over on friday at .29 and next week we go south again. Sorry, but just one little good release does not turn a bad quarter of a year of PLPL to a good one.
Stay cool. I do not buy now as I wait for the next flop after todays 'thrill'. That's the way pennyies work, sorry , MO.
I am impressed if Duffield is honest. This decision by the management of Plandai sounds a bit different - in a positive way - compared to their usual lousy behaviour towards shareholder. Finally something positive - if honest.
Be careful - still on a downtrend since half a year with regards to this very clear and unpleased chart curves :
http://ih.advfn.com/p.php?pid=webchart&btn=s_ok&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=USOTC%3APLPL&s_ok=Get+Chart&period=4&drawmode=2&size=18&volume=1
Too many 'bottoms' which have been traps ! More down than up, not really an end in sight, so below .20 might be an option if management goes on with this kind of 'progress' and information politics
This 'loading zone' could be realistic - friday - usually a selling day at PLPL - maybe not this time as some might believe that anything near .20 could be their loading zone. IMO selling will coninue next week - if nothing happen before. Maybe than we go below .20. - guess .19 or .18 and than some will load again. Just IMO.
Sweet 'letter' - unfortunately managements of pennystocks do not give a piece of xxxx about the opions, worries and losses of shareholder ! And PLPL management , especially a millionair like Shively, are not different. His reputation exists in his millions and not in his interst to be respected by any shareholder. They are all the same.
Fortunately I leanred my lessen and justz sepculate with free shares.
I speculate with gains I made by PLPL and not with by invested money. Thus I follow this stock - otherwise I wouldn't! And I follow this stock still because I can not make any losses but might see another hype if anything significant will be released. But, for me no doubt, this story will be fogotten in 2 years as the way this management runs this story and this stock is ridiculous meanwhile and not trustworthy. My pessimism has tons of arguments which I called even at a long list. But, no question, with a name like Shively and with a stockmarket, waiting for clinical results, PLPL has nevertheless a chance for a mid term turn around. But it will never ever again see anything above $1.50. I do not speculate on anything else but on such a little hype. I am 90% pessimistic about any future of PLPL because there are lots of lies existing. But I am optimistic 10% that the stockmarket is dump enough to get in again in autumn after this or that - a bit more promising - news release. Gambler will kick on such news - and thus I believe we might see .50 or .60 again midterm. So, most here will be happy and longterm shareholder, who didn't sell a bunch of their shares at 1.00 - as I did - will hate PLPL. And, no doubt, if PLPL goes on like this, we will be able to read a lot of hate posts here about Plandai. Remember my words.
If you love to lose money, buy now. If you are careful, wait for signs. If you like high risks, buy at .20 some shares and hope for .30.
Regarding PLPL I just can repeat what a very famous european speculator has said:
If you have a lot of money you may speculate.
If you have just a bit of money you should never specualte.
If you have no money at all you must speculate.
Friends, you obvioulsy do not read posts - or maybe just my posts - here properly at all otherwise I must not repeat my PLPL investment strategy - or should I call it PLPL tragedy - again and again and how much I sold and why I keep this or that and so on.
Forget it.
Bottom? Which bottom? Has been at .50 .40 .30. so which bottom........... .20. 15. 10. .05 ?!?
Always the same arguments without any value
Sept 3 http://www.plandaibiotech.com/bioavailability_trial_preliminary_results.pdf
Does this thrill? Not really..... another...and? so what?!
Agree. Good post. PLPL management does everything to destory the reputation and finally just a new pump will lever the price up again - but imo not that much anymore as in the beginning. This dream is over as at 90% of pennystock - which are all identical in wonderful promises, increasing delays, silence after two years and significantly low revenues as long as they exist!
If Shively is really a serious person, ex-director of Microsoft, he would have been much more careful to get into this gray stroy without anything real.
He might have a vision regarding MJ, but I have problems to understand his vision with a company like PLPL. I assume Shively just tries PLPL as long as Duffield can make him believe that the extraction process of PLPL is useable for MJ as well (Phytofare does not interest Shively at all, I do not doubt about this).
In the moment when Duffield can not prove that his methods works fine for MJ, Shively is out. No doubt - otherwise, what else should Shively look for at PLPL?!
I hope my pessimism is exxagerated - but unfortunatley I have seen too many pennies leaded by liars who did empty the companies treasure by fillings their pcokets with salaries, shares, options, etc.
It's a trap current and nothing else. Nobody should buy one single share anymore before management has proved that phytofare is a product ready for sale. Mylesson after 18 years of microcap speculation:
Do not trust ANY management as long as they only talk and did not deliver ! Words are just words and it NEVER has been clever to follow words only.
Some months ago I received negative comments about my prediction that PLPL might go below .30. For some here stocks are not predictible: Unfortunately 18 years of endless experiences with such stocks without any revenue and ready product and visible business - just promises about progress - have 1000 times more value than any word by a management which never ever did prove to be able to create real, trustworthy and stable shareholder value.
PLPL appeares to be a very risky specualtion - i.E. Shively leaves PLPL this story goes sdup penny - I am very happy I specualte with free shares and I hope some here are in the same situation. I will buy again - between .17 and .20 - to be honest. Not now at all.
By the wy: Very poor also: No word by the management, no letter by the CEO, no sing of responsibility of tons of delays, not even a proper bloc at PLPL homepage. Poor as poor can be by a penny story.
Enormously low volume meanwhile - reminds me unfoprtunately on 2012 when nobody has been interested in PLPL. Not sure .25 will keep long, still a market cap of nearly $30.000.000 for nothing but a promise, a missing final medical report and for zero news from all management - not to forget a dead blog at the homepage of PLPL.
Very funny by a biotech company which tries to make the stockmarket believe they are going to change the medical world.
Not worth to moderate this dead stock. It will anyway not progress, just a tiny gold story which even the management is not able to develop.
Good luck to all. I am gone.
Indeed ! No news anymore but we are thrilled lol
Honestly said: PLPL is not worse than all the other penny gambles:
exxagerated promises in the first quarter
wonderful news releases about progress in the second quarter
stalling tactics in the third quarter
excuses in the last quarter
silence at the end.
We still have a chance: PLPL is - IMO - still in the third quarter.
A 'bio-tick-shack' - whatever this shall be - take it as german sarcasm.
I just hope that I will not be the one at the end who laughs best - as I would hate it to see another '10-bagger' to die
As I said: I will buy only at .20 when it goes lower and will buy at .35 if a signal has substance.....Still no signal and still falling - no buy from my side. I do not want any loses and I will be happy with lower gains if I feel sure than gains will be made. Currently - and maybe for the next two months - I can not see anything good here to accumulate. No doubt, meanhwile .20 is an option.
I am in since .16 and sold at 1.10 to receive back my investment which means I speculated with free shares - but what the hell does this have to do with my solidarity with those who have been screvved by false promises by a management? I have been often in such a situation in the past and do not like at all how shareholder, who did believe the release of PLPL,got cheated.
yes - and for all those $ 2.50 buyers daytrader and gambler like the final handfull of bullboard members will have a nice and sarcastic wording " Hope you still have if you have nothing anymore" LOL